Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,628	Closed	-$5.32M	–	85
2023 Q4	$5.32M	Hold	59,628	–	–	1.06%	32
2023 Q3	$4.43M	Hold	59,628	–	–	0.94%	31
2023 Q2	$4.94M	Hold	59,628	–	–	1.02%	32
2023 Q1	$4.45M	Buy	59,628 +49,355	+480%	+$4.1M	1.02%	35
2022 Q4	$848K	Hold	10,273	–	–	0.2%	77
2022 Q3	$809K	Hold	10,273	–	–	0.19%	80
2022 Q2	$756K	Hold	10,273	–	–	0.17%	81
2022 Q1	$916K	Hold	10,273	–	–	0.16%	80
2021 Q4	$1.15M	Hold	10,273	–	–	0.19%	81
2021 Q3	$1.29M	Hold	10,273	–	–	0.24%	76
2021 Q2	$1.39M	Hold	10,273	–	–	0.25%	75
2021 Q1	$1.39M	Hold	10,273	–	–	0.29%	66
2020 Q4	$1.45M	Buy	10,273 +963	+10%	+$123K	0.32%	64
2020 Q3	$1.04M	Hold	9,310	–	–	0.36%	48
2020 Q2	$1.04M	Hold	9,310	–	–	0.43%	53
2020 Q1	$721K	Hold	9,310	–	–	0.53%	50
2019 Q4	$885K	Hold	9,310	–	–	0.57%	53
2019 Q3	$843	Hold	9,310	–	–	0.36%	51
2019 Q2	$843K	Buy	+9,310	New	+$794K	0.64%	46
2019 Q1	–	Sell	-9,310	Closed	-$668K	–	61
2018 Q4	$668K	Buy	+9,310	New	+$750K	0.67%	37

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's XBI Position: Q1 2024 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 59,628 shares — an estimated $5.32M sold.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in XBI in Q4 2018 and held it in 20 quarters. The position peaked at $5.32M in Q4 2023. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold 59,628 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $5.32M.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 20 quarters.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's State Street SPDR S&P Biotech ETF position peaked at $5.32M in Q4 2023.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q1 2024, filed 1 May 2024.